Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02774187 |
Recruitment Status :
Completed
First Posted : May 17, 2016
Last Update Posted : December 5, 2019
|
Sponsor:
Sun Yat-sen University
Collaborators:
First Affiliated Hospital, Sun Yat-Sen University
Kaiping Central Hospital
Guangzhou No.12 People's Hospital
The First Affiliated Hospital of University of South China
Information provided by (Responsible Party):
Shi Ming, Sun Yat-sen University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | July 2017 |
Actual Study Completion Date : | August 2018 |
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):